Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) CEO and leadership

Zippia score 4.3
OverviewRevenue

Reviews

DemographicsCompetitors

CEO & Executives

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) CEO and executives

Executive Summary. Based on our data team's research, Harry J. Smolen is the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s CEO. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has 31 employees, of which 54 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executive team is 80% female and 20% male.
  • 61% of the management team is White.
  • 17% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?
Share your experience

Rate International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Harry J. Smolen

President & CEO

Programa - Português

Board Member

Marlene Gyldmark

Board Member

Nancy S. Berg

Board Member

Andrea Manca

Board Member

Betsy Lane

Board Member

Bianca Kovalenko

Board Member

Bre Schmidt

Board Member

Brian Gaines

Board Member

Carley Roberson

Board Member

Do you work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

Does leadership effectively guide International Society for Pharmacoeconomics and Outcomes Research (ISPOR) toward its goals?

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) jobs

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) board members

Name & TitleBio
Programa - Português

Board Member

Marlene Gyldmark

Board Member

Nancy S. Berg

Board Member

Andrea Manca

Board Member

Betsy Lane

Board Member

Bianca Kovalenko

Board Member

Bre Schmidt

Board Member

Brian Gaines

Board Member

Carley Roberson

Board Member

Christie Cunningham

Board Member

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) leadership demographics

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) gender distribution in management team

  • The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executive team is 80% female and 20% male.
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is 57% female and 43% male company-wide.
Male
Male
20%
Company-wide: 43%
Female
Female
80%
Company-wide: 57%

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executives by race

Management Team:
  • The most common ethnicity among International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executive officers is White.
  • 61% of the management team is White.
  • 17% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s management is Hispanic or Latino.
  • 10% of the management team is Asian.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 63% of employees are White.
  • 13% of employees are Black or African American.
  • 11% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) jobs nearby

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) executives FAQs

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of International Society for Pharmacoeconomics and Outcomes Research (ISPOR), including salaries, political affiliations, employee data, and more, in order to inform job seekers about International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The employee data is based on information from people who have self-reported their past or current employments at International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data presented on this page does not represent the view of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and its employees or that of Zippia.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) may also be known as or be related to INTERNATIONAL SOCIETY FOR, International Society For Pharmacoeconomics And Outcomes Research ..., International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Joshua Friedman.